|
Market Closed -
Other stock markets
|
After hours 14:08:57 | |||
| 337.50 EUR | 0.00% |
|
338.50 | +0.30% |
| 07-29 | Virbac, without the alibi |  |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 16.56x | 2.21x | 1.25x | 1.9x | 9.37x | 11.63x | 0.51% | 3.25B | |
| 12.09x | 8.58x | 1.96x | 4.03x | 9.2x | 10.4x | 2.78% | 32.4B | |
| 269.08x | 2.03x | -2.23x | 3.19x | 16.11x | 18.67x | -.--% | 13.17B | |
| 7.75x | 1.13x | 0.05x | 1.11x | 4.11x | 6.34x | 3.38% | 3.84B | |
| 53.47x | 2.51x | 0.33x | - | - | - | 0.67% | 2.04B | |
| 34.04x | 2.18x | 0.66x | 3.87x | 13.79x | 20.03x | -.--% | 1.89B | |
| 14.68x | 3.9x | 0.14x | 1.35x | 8.02x | 9.51x | 1.31% | 1.47B | |
| 17.44x | 1.58x | 1.63x | 2.19x | 10.1x | 15.62x | 1.76% | 1.14B | |
| 32.7x | 1.14x | 1.7x | - | - | - | 0.46% | 989M | |
| 15.42x | 1.28x | -3.72x | 1.1x | 5.25x | 7.43x | 1.27% | 976M | |
| 12.9x | 1.38x | 1.06x | - | - | - | - | 895M | |
| 18.34x | 1.98x | -1.46x | - | - | - | 1.11% | 619M | |
| 20.78x | 1.38x | -2.81x | - | - | - | - | 526M | |
| 23.43x | 0.5x | 0.14x | 1.72x | 8.25x | 17.05x | 1.93% | 369M | |
| Average | 39.19x | 2.27x | -0.09x | 2.27x | 9.36x | 12.97x | 1.27% | 4.54B | |
| Weighted average by Cap. | 68.01x | 5.33x | 0.62x | 3.36x | 10.50x | 12.45x | 1.82% |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
